Capricor Therapeutics (CAPR) Announces Statistically Significant Data from CAP-1002 DYNAMIC Trial in Adv. Heart Failure
Tweet Send to a Friend
Capricor Therapeutics, Inc. (Nasdaq: CAPR) announced detailed results from its DYNAMIC clinical trial of CAP-1002 in patients with advanced heart ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
